Black Diamond Therapeutics Inc

General ticker "BDTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $139.3M

Black Diamond Therapeutics Inc follows the US Stock Market performance with the rate: 3.9%.

Estimated limits based on current volatility of 5.0%: low 2.19$, high 2.42$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.03$, 4.93$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.93$, 4.66$]

Financial Metrics affecting the BDTX estimates:

  • Negative: Non-GAAP EPS, $ of -1.88 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -36.83 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31
  • Negative: Industry operating profit margin (median), % of -98.30 <= 2.14

Similar symbols

Short-term BDTX quotes

Long-term BDTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $126.87MM $92.83MM $86.46MM
Operating Income $-126.87MM $-92.83MM $-86.46MM
Non-Operating Income $1.28MM $1.66MM $4.02MM
R&D Expense $96.83MM $64.44MM $59.35MM
Income(Loss) $-125.60MM $-91.17MM $-82.44MM
Profit(Loss) $-125.60MM $-91.17MM $-82.44MM
Stockholders Equity $195.90MM $115.69MM $116.74MM
Assets $247.68MM $156.25MM $158.57MM
Operating Cash Flow $-100.15MM $-85.08MM $-66.72MM
Capital expenditure $2.71MM $0.19MM $0.03MM
Investing Cash Flow $130.61MM $53.37MM $16.35MM
Financing Cash Flow $0.73MM $0.18MM $71.93MM
Earnings Per Share* $-3.40 $-2.33 $-1.88

* EPS are Split Adjusted, recent splits may be reflected with a delay.